A startup employee staring down a 90-day post-termination window to exercise vested ISOs finds all three companies within about ten minutes of searching. Secfi, ESO Fund, and EquityBee each present their offer as the obvious answer to a cash problem that’s very real: exercising options costs money, and the resulting tax bill can add another large number on top.
This is not tax or financial advice. The stakes are high enough that getting the decision wrong — or right, but for the wrong reasons — can mean owing five or six figures on stock that’s illiquid and might end up worth nothing. Every path here trades something for something, and none of it is reversible once signed.
The short version: Secfi and ESO Fund both front non-recourse cash for a fee plus a slice of eventual gains — Secfi has been described as leaning on an accruing, interest-style charge, ESO Fund on skipping ongoing interest in favor of a larger one-time equity cut, though terms should be confirmed directly with each. EquityBee is structurally different — a marketplace that shops the exercise request to accredited investors rather than a company financing it directly. None of the three hands out free money. For a meaningful share of people who land on these sites, paying cash or not exercising at all comes out ahead. A CPA or CFP who specializes in equity compensation should be part of this decision before anything gets signed.
The Problem: Exercising Options Costs Real Cash (Strike + AMT)
Vested stock options are not free money sitting in an account. Exercising means paying the strike price times the number of shares, in cash, before any of that stock can be sold.
For incentive stock options (ISOs), the gap between the strike price and the current fair market value — the “spread” — can also trigger the Alternative Minimum Tax in the year of exercise, even though no shares were sold and no cash came in from the transaction. This is generally where the math gets painful: a real tax liability shows up on paper gains that can’t be touched.
The exact dollar amount depends on the full tax return — filing status, other income, state taxes, and more — so no specific threshold or rate belongs in a general article like this one. What can be said plainly: it’s possible to owe a real AMT bill this year on stock that stays illiquid, and if the company fails, that stock can go to zero while the tax bill does not refund itself.
The 90-day clock after leaving a job is designed to create urgency, and it does. But most of the bad outcomes in this space trace back to signing something quickly instead of modeling the downside first. A few extra days spent getting real numbers from a CPA rarely costs as much as a rushed decision.
How Each Provider Actually Works
All three companies run real underwriting — grant documents, share count, strike price, and the company’s most recent 409A valuation all get reviewed before any money moves. None of this is instant, and none of it is guaranteed to close.
Secfi offers non-recourse financing: it fronts the strike price and, often, the cash needed to cover the AMT hit. Non-recourse means that if the stock ends up worthless, the borrower generally owes nothing beyond forfeiting the collateral shares. In exchange, Secfi’s arrangement has been described — in its own FAQ and in third-party comparisons — as combining an interest-style charge that accrues over time with a percentage of the equity or proceeds. Current terms should be confirmed directly, as none of this is fixed or published as a flat rate.
ESO Fund also provides non-recourse financing but is reported to structure it differently: rather than charging ongoing interest, it takes a larger one-time share of proceeds at a liquidity event. It’s generally positioned as faster to close than Secfi’s process.
EquityBee is not a balance-sheet lender at all — it’s a marketplace. The company packages an employee’s exercise request and shops it to a pool of accredited investors who compete to back it in exchange for a negotiated share of future proceeds. EquityBee takes its own placement and administrative fees on top of whatever the investor negotiates, and has reportedly run eligibility, background, and credit checks on applicants. That’s a structurally different arrangement than dealing with a single financing company: the employee is effectively negotiating a stranger-investor’s terms, brokered by a platform that also has its own fee built in.
One user on r/fatFIRE summarized the core mechanism behind the lending model plainly: “ESO and ECP work by giving you an unsecured loan against the upside of your shares… The downside is it can be pretty expensive to lose a percentage of that upside.” That’s the trade in a sentence, and it applies to Secfi and ESO Fund alike — the marketplace model just moves the counterparty from a company’s balance sheet to an individual investor.
The Real Cost: What You Give Up
None of this is a simple fee for a service. It’s a trade: cash now, in exchange for giving up a slice of upside later, plus fees regardless of outcome. That structure is expensive precisely when the company does well and “free” only in the scenario where the company fails and the equity is worth nothing anyway.
Suppose, purely as an illustrative hypothetical with no bearing on any real quote, a $50,000 exercise cost turns into a company acquired for a life-changing sum five years later. Whatever percentage was signed away up front now applies to a much bigger number. That’s the scenario these companies are underwriting against, and it’s why the terms matter more than the headline “non-recourse” label.
That label itself creates a common misconception. One user on r/personalfinance summed up the appeal this way: “I don’t have to repay the amount if there is no liquidation event or if the company goes bankrupt (so zero risk).” Non-recourse does mean no personal liability beyond the collateral shares if the company fails — but “zero risk” overstates it. Set-up fees, administrative charges, and any accrued interest are frequently non-refundable regardless of outcome, and the upside given away only has value if the company succeeds, which is exactly the scenario in which the cost bites hardest.
Pricing power in this space also isn’t symmetric. As one commenter on r/fatFIRE put it: “Companies like Sec Fi set their pricing around the assumption that you don’t have many other options available to you.” That’s a fair read of the incentive structure — someone facing a 90-day deadline with no cash on hand is not in a strong negotiating position, and these companies know it.
Actual quoted terms vary a lot and should never be treated as a market rate. One user on r/fatFIRE described comparing two competing offers: “one platform is asking for 40% of shares (no interest on the loan) while the other is asking for 30% + interest on the loan + 5% of net proceeds.” That’s one individual’s specific quote at a specific point in time, not a published price list — but it illustrates how differently two providers can structure the same underlying trade.
A more detailed, and more critical, account appeared on r/fatFIRE from a user describing a past experience with one of these financing arrangements: “DO NOT WORK WITH THEM… automated fee every month… $125 + a fee to set up ($1k) and upon exit ($1500)… ridiculously high interest fee which compounds… lender of last resort.” That’s one person’s reported experience, likely reflecting terms and pricing at the time they signed, and it should not be read as current pricing for any specific provider. It’s worth taking seriously anyway, because it captures a pattern other users describe too: fees that show up monthly, at setup, and at exit, on top of whatever percentage was negotiated up front.
Non-recourse financing is often marketed as risk-free. In practice, it functions as a cost-of-capital trade: the fee and equity share owed both scale with a successful outcome, so the arrangement tends to be most expensive in the scenario everyone signing up is hoping for.
Does Secfi’s Maeve AI Actually Help?
Secfi runs a free AI assistant called Maeve, available at secfi.com/maeve, built on the company’s proprietary tax modeling engine. It’s designed to model ISO, NSO, and RSU scenarios, including AMT exposure, and can import grant data directly from Carta.
For someone who has never touched an AMT worksheet, Maeve genuinely lowers the barrier to understanding the shape of the problem. Getting a fast, accessible model of exercise cost and potential tax exposure beats staring at IRS instructions cold, and that’s a real point in its favor.
It is not neutral, however: Maeve is built, hosted, and financially incentivized by a company that also sells non-recourse financing, and a scenario tool from the seller of the product it’s modeling is not the same thing as independent advice. There’s also no established public or community track record yet on how accurate Maeve’s outputs actually are in practice; that gap should be stated honestly rather than papered over in either direction.
This mirrors a broader question worth asking about any AI tool that sits inside a company selling a financial product — whether an AI financial assistant actually replaces a human advisor or simply makes the pitch feel more personalized. Maeve is a reasonable starting model to bring to a CPA. It is not a substitute for one. A free tool built by a company that profits when the exercise decision goes through its own financing product should not be assumed unbiased just because it costs nothing to use.
When to Skip All Three (Or Not Exercise at All)
None of the three providers is the default right answer, and doing nothing is a legitimate option that gets far less attention because it doesn’t generate revenue for anyone.
Paying cash, if the exercise cost and any resulting AMT liability can be covered without touching an emergency fund, avoids giving up equity or paying fees entirely. It’s the cleanest outcome when it’s affordable.
Letting unexercised options lapse is also a reasonable choice when the company’s future looks shaky. A $0 loss on options that were never exercised beats a real tax bill on stock that turns out to be worthless.
A partial exercise — using only cash that can be fully afforded to lose, and letting the rest of the grant lapse — splits the difference for people who believe in the company but don’t want to bet everything on it.
And bringing in a professional, rather than a financing company, is worth serious consideration before signing anything. Hiring a human CFP who specializes in equity compensation costs money up front but doesn’t take a cut of future upside.
One r/fatFIRE user framed the calculus for when financing actually makes sense: “I would only engage with SecFI if you planned to or had already left the company and needed to do this quickly due to 90 day expiration of options…” That’s a narrower use case than the marketing suggests — a real deadline with a real company, not a general-purpose way to acquire equity cheaply. The same thread carried a caution worth repeating: “Don’t even think about counting these shares as money yet… Don’t take loans out against it…” Illiquid equity, financed or not, isn’t cash until there’s an actual liquidity event.
This is not tax or financial advice, and given the dollar amounts and irreversibility involved, a CPA or CFP with equity compensation experience should be consulted before acting on any of it.
How to Decide: What to Verify Before You Sign Anything
A short checklist before contacting any of these three, or signing with any of them:
- Pull the real grant documents and the company’s most recent 409A valuation first. Nothing else can be evaluated accurately without these numbers in hand.
- Get full economics in writing from each provider being considered — the fee amount, whether interest accrues and at what pace, and the exact percentage of equity or proceeds owed. Compare offers side by side rather than taking the first one that closes fast.
- Confirm the company’s stock plan doesn’t restrict third-party financing. Transfer restrictions or rights-of-first-refusal clauses can complicate or block these arrangements entirely, and that’s worth knowing before signing anything.
- Run the actual AMT scenario through real tax software or a CPA, not just a vendor’s calculator. A tool built to encourage exercising is not the same as a neutral tax projection, and software that can handle the resulting AMT paperwork is a reasonable next step once real numbers are in hand.
- Zoom out beyond this one decision. Modeling a potential liquidity event inside a full financial-planning tool makes it easier to see how giving up a slice of equity affects the entire financial timeline, not just this one transaction.
Our Take
If speed matters — a real 90-day clock, a company the departing employee is genuinely confident in — ESO Fund’s reported no-interest, one-time-equity-share structure is the most straightforward to evaluate under time pressure. Fewer moving parts means fewer places for the math to get confusing when there isn’t much time to think it through.
For someone who can slow down, negotiate, and wants scenario modeling along the way, Secfi’s tooling is genuinely useful, with Maeve as a starting point rather than a final answer. The caveat stands: assume the tool exists to route toward Secfi’s own financing, and get any output checked independently before acting on it.
EquityBee makes sense for someone who specifically wants to shop the deal to multiple investors rather than accept one company’s take-it-or-leave-it terms. The marketplace structure can work in an applicant’s favor on price, but it comes with more paperwork and a credit and background check that the other two don’t require in the same way.
The honest bottom line: for a meaningful share of people who land on these three sites, the right move is none of them. Paying cash when it’s affordable, walking away when the company’s prospects look shaky, or hiring an equity-compensation CPA before doing anything else all beat signing away a slice of future upside under time pressure.
The Verdict
Secfi, ESO Fund, and EquityBee all solve a real cash problem, and all three charge for it — in fees, in equity, or in both. The right choice depends on the actual numbers in a specific situation, not on whichever landing page got clicked first.
The practical next step: pull the grant documents and 409A valuation, get written quotes from at least two of these providers or price out paying in cash, and run the AMT exposure past a CPA who specializes in equity compensation before signing anything.
The 90-day clock creates real time pressure, and the fine print in these financing agreements deserves the same level of scrutiny before anything gets signed.
FAQ
Is it worth using Secfi, ESO Fund, or EquityBee to exercise stock options?
It depends on the individual’s cash position, conviction in the company, and the specific terms offered. For someone who can afford to pay the strike price and any AMT in cash, these services generally add cost without adding value. For someone facing a real deadline with no cash available and genuine confidence in the company, they can make an otherwise-impossible exercise possible — at the cost of a real slice of future upside.
What happens if my startup fails after I use one of these financing companies?
With Secfi or ESO Fund’s non-recourse structure, the individual generally isn’t personally liable beyond forfeiting the collateral shares if the company fails — but any fees already paid, including setup or administrative charges, are typically non-refundable. With EquityBee, terms are negotiated per-investor, so the outcome depends on the specific agreement signed. None of this eliminates the underlying tax exposure that may have already been triggered by the exercise itself.
Do I still owe AMT if I use a financing company to exercise?
Generally, yes — the AMT exposure comes from the act of exercising ISOs at a spread above the strike price, regardless of how the exercise was funded. Some of these providers offer to front the AMT cash specifically because that liability doesn’t disappear just because a third party paid the strike price. A CPA should confirm how this applies to a specific tax return.
What’s the difference between Secfi/ESO Fund and EquityBee?
Secfi and ESO Fund are direct non-recourse lenders — the company itself fronts the cash and takes a fee and/or equity share in return. EquityBee is a marketplace that connects applicants with individual accredited investors who negotiate their own terms, with EquityBee collecting placement and administrative fees on top. The EquityBee process also reportedly includes background and credit checks that the direct lenders don’t require in the same way.
Can I negotiate the terms with these providers?
With EquityBee, yes — the marketplace structure means multiple investors can compete for the deal, which creates room to negotiate. With Secfi and ESO Fund, terms are reportedly less flexible on an individual basis, though getting multiple quotes and comparing them in writing is still worth doing before signing with either.
Is there a cheaper way to fund exercising my stock options?
Often, yes: paying the strike price and any AMT in cash, if affordable, avoids giving up any equity or paying financing fees entirely. A partial exercise using only cash that can be comfortably afforded is another option. For some people, the cheapest path is simply not exercising and letting the options lapse — especially when the company’s prospects are uncertain.
